Delineating the role of BCL-2-associated athanogene 1 (BAG-1) in human breast cancer

Download files
Access & Terms of Use
open access
Copyright: Anderson, Luke Russell
Altmetric
Abstract
Breast Cancer is the leading cause of cancer deaths in females in Australia. The hormone estrogen is a major aetiological factor in breast carcinogenesis, however, estrogen’s role as a survival factor in breast cancer growth and response to therapy is less well defined. The estrogen-regulated survival gene, BAG-1, is often overexpressed in breast cancer, however, its role in breast carcinogenesis and response to endocrine treatments is poorly defined. This study has shown that BAG-1 overexpression may play a role in breast cancer initiation by attenuating luminal apoptosis in MCF-10A acini leading to an ablation of lumen formation and that this process was dependent on RAF-1 activation and subsequent enhancement of downstream MAP kinase signalling resulting in ERK-mediated BIM degradation. To determine whether BAG-1 may cooperate with known oncogenes commonly overexpressed in breast cancer such as c-MYC and therefore play a role in breast cancer progression, BAG-1 was co-overexpressed with c-MYC in the MCF-10A 3-D model. However, c-MYC had no significant effects on apoptosis compared to controls and thus when co-expressed with BAG-1, the functions of BAG-1 predominated resulting mature acini resembled BAG-1 only expressing structures. Furthermore, co-expression did not further enhance the c-MYC-mediated transformed acinar morphology suggesting that BAG-1 does not cooperate with c-MYC to enhance c-MYC mediated tumorigenesis. To understand the role of BAG-1 on the response to antiestrogens in ER+ breast cancer, BAG-1 was overexpressed in the MCF-7 ER+ breast cancer cell line and the response to antiestrogens was investigated. BAG-1 both attenuated tamoxifen-induced apoptosis while enhancing the sensitivity of MCF-7 cells to the growth inhibitory effects of antiestrogens. Furthermore, the latter provides a potential in vitro mechanism for recent clinical data examining the influence of BAG-1 on response to endocrine treatments and outcome in ER+ breast cancer patients. Thus BAG-1 overexpression in a 3-D model, which correlates with mammary acinar morphogenesis in vivo, suggests that BAG-1 may contribute to breast cancer initiation, however, BAG-1 overexpression also correlated with improved response to endocrine therapy and patient prognosis. An explanation for this apparent dichotomy in BAG-1 function may involve BAG-1 playing an important role during tumour initiation; however, this ultimately leads to the formation of less aggressive, more therapeutically responsive tumours and improved breast cancer patient survival.
Persistent link to this record
Link to Publisher Version
Link to Open Access Version
Additional Link
Author(s)
Anderson, Luke Russell
Supervisor(s)
Butt, Alison
Sutherland, Rob
Creator(s)
Editor(s)
Translator(s)
Curator(s)
Designer(s)
Arranger(s)
Composer(s)
Recordist(s)
Conference Proceedings Editor(s)
Other Contributor(s)
Corporate/Industry Contributor(s)
Publication Year
2010
Resource Type
Thesis
Degree Type
PhD Doctorate
UNSW Faculty
Files
download whole.pdf 2.04 MB Adobe Portable Document Format
Related dataset(s)